The EU Commission issued a draft guideline for claims substantiation in July of 2013. The FDA and the FTC are carefully watching cosmetic products for non-substantiated misleading claims. Ethical issues are raised by misleading claims as the product will not deliver the promised results.
With the skin care industry striving to produce safer products, it should also improve its testing methods to better evaluate a product’s activity on the skin and to clearly and accurately communicate the results in product claims. These topics will be explored at a one-day event held by the Center for Dermal Research, Sept. 15 at the Life Sciences Building/Busch Campus of Rutgers University in Piscataway, NJ.
This course is tailored to provide key aspects in the establishment of best practices to be applied in experimental design and tie it into the regulatory framework rationale, according to CDR.
The course director is Nava Dayan.
More info: NJ Center for Biomaterials, Email: email@example.com